Donald Trump's move to cut drug prices in America can potentially turn out to be a $35 billion additional cost to the federal ...

A MAJOR review has pitted three blockbuster fat jabs against each other – comparing weight lost and how long users were able ...

WHEN the price of Mounjaro shot up last month, user Aimee Young made the decision to come off the jabs completely. Eight weeks post-jabs, the 38-year-old has managed to maintain the weight she ...

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech ...

Through an exclusive partnership with Eli Lilly, the company has begun distributing and promoting Yurpeak (Tirzepatide) in ...

GLP-1 receptor agonists like Wegovy, Saxenda and Zepbound will be restricted in Michigan ... than $409 million in the 2024 fiscal year on GLP-1s before any discounts or price concessions. DHHS said ...

Blockbuster drugs such as Ozempic have moved the dial on Chemist Warehouse sales which were 17 per cent higher through the first quarter of the 2026 financial year.

Teva reports revenues of $4.5 billion in the third quarter of 2025, an increase of 3% year-over-year (YoY) in U.S. dollars or 1% in local currency (LC). Excluding Japan BV in Q3 2024, revenues ...

Lilly moved first. In January 2024, it launched LillyDirect, linking patients with telehealth providers and home delivery for its diabetes and weight-management portfolio. Pfizer followed in August ...

Application error: a client-side exception has occurred (see the browser console for more information).

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...